-
Short-acting insulin market to cross $9b by 2030
The global short-acting insulin market is anticipated to exceed $9 billion by 2030, largely fueled by the increasing prevalence of diabetes, according to DelveInsight. Key factors driving this growth include significant technological advancements and evolving healthcare policies. The report highlights that innovations in insulin analogues and improvements in delivery mechanisms, such as insulin pumps and…
-
Pakistan’s Pharmaceutical Sector Faces Challenges Despite Plans for Economic Zone
Despite the country’s ambitious plans to establish a Pharmaceutical Economic Zone, Pakistan’s pharmaceutical industry is expected to grow at a slower pace compared to its neighboring South Asian markets. According to a report by BMI, the sector is projected to reach $1.9 billion by 2028, with a modest compound annual growth rate (CAGR) of 1.1%…
-
Boston Institute of Biotechnology & BiBo Pharma CEO Wins 2024 Global Biologics CDMO Technology Leadership Award
The Boston Institute of Biotechnology, LLC (BIB) is proud to announce that its CEO has been awarded the prestigious 2024 Global Biologics CDMO Technology Leadership Award from Frost & Sullivan. This recognition celebrates BIB’s groundbreaking contributions to biologics manufacturing, including the world’s first 30,000L bioreactor and its Grand-CHO platform, which are revolutionizing the production of…
-
After BIOSECURE Act passes in House, targeted Chinese companies say they’re ‘deeply’ concerned
After much anticipation and concern, the BIOSECURE Act—which would prevent U.S. companies from working with certain Chinese biotech service providers—has passed a key threshold. Late Monday, the U.S. House of Representatives voted 306-81 in favor of the bill, which was introduced in January and seeks to halt federal contracts with five named Chinese life-sci companies—WuXi…
-
FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered issues ranging from a lack of sanitary procedures to improper data collection and monitoring. The manufacturers in Japan, Otsuka Pharmaceutical and Taenaka Kogyo, received their Form 483s in the spring. The FDA posted the documents on…
-
Natural remedies for everyday illnesses
I wish that being a doctor meant that my family and I would never get sick. Unfortunately, viruses, bacteria and other sources of illness do not discriminate based on profession. Here’s what’s in my toolkit to keep us going in sickness and in health. Natural remedies for cough and sore throat *Try each of these…
-
Drinking This Many Cups of Coffee Each Day Could Put Your Heart Health at Risk
Fast Fact There’s nothing like a dose of caffeine on a groggy morning to give you a much-needed boost of energy—but new research suggests drinking too much caffeine could be bad news for your heart health. In the U.S., it’s estimated that about 85% of people drink at least one caffeinated beverage a day. Whether…
-
7th Pakistan Pharma Summit & PESA 2024: A Groundbreaking Event in AI and Pharmaceutical Innovation
Join the most anticipated event in Pakistan’s pharmaceutical industry – the 7th Pakistan Pharma Summit, taking place on September 25th, with a special CEO Masterclass on September 24th. This prestigious event will gather industry leaders, policymakers, and global experts to explore how AI can revolutionize efficiency and innovation in the pharmaceutical sector. Alongside, the PESA…
-
Leishmaniosis: KP scientists discover indigenous drug for treatment
PESHAWAR: A duo scientists in medicine have succeeded to prepare an indigenous drug for treatment of Cutaneous Leishmaniasis (CL), a painful skin disfiguring and constantly on rise in Khyber Pakhtunkhwa province during the last few years. The scientists from Khyber Medical University (KMU) and Gomal University D.I. Khan worked over for over five years and…
-
Medicine production: PPMA urges PM to withdraw 17pc tax on raw materials
ISLAMABAD: The Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has urged Prime Minister Shehbaz Sharif to immediately withdraw the unjust 17 percent general sales tax imposed by the Imran Khan government on raw materials used for medicine production. According to Dr Kaiser Waheed, the official spokesperson of the PPMA, the decision of the previous government to impose…